代æ¿ãããã¤ã¿ã¤ãã£ã¦è¨ã£ããåå¼å ã®ãããä»äºã§ããããªãªã¼ã©ãã£ã¦çå½åãã³ãã³åºã¦ãé«åå©ãä¸ãé¨é·ã« ããã¤ã¬ã¨ãç¬ãã£ã¦ç¬ãããæã¶ã£æ®ºãã¦ããããã¨æã£ã
代æ¿ãããã¤ã¿ã¤ãã£ã¦è¨ã£ããåå¼å ã®ãããä»äºã§ããããªãªã¼ã©ãã£ã¦çå½åãã³ãã³åºã¦ãé«åå©ãä¸ãé¨é·ã« ããã¤ã¬ã¨ãç¬ãã£ã¦ç¬ãããæã¶ã£æ®ºãã¦ããããã¨æã£ã
ã¹ãã¼ãçæ³ï¼ã¹ãã¼ããããã»ããSchema therapyï¼ã¨ã¯ãã¸ã§ãã§ãªã¼ã»ã¤ã³ã°ï¼è±èªçï¼ï¼Jeffrey E. Youngï¼ã«ããéçºãããããã¼ã½ããªãã£é害ããã³DSM-I軸é害ã®æ²»çæ³ã§ãããä»ã®æ²»çæ³ï¼ä¾ãã°ä¼çµ±çãªèªç¥è¡åçæ³ï¼ãªã©ã«å¹æã示ããªãããããã¯åçºããã±ã¼ã¹ã«ç¨ãããã¦ãããã¹ãã¼ãçæ³ã¯ãèªç¥è¡åçæ³ãç²¾ç¥åæ対象é¢ä¿è«ãæççè«ãã²ã·ã¥ã¿ã«ãçæ³ãªã©[1]ã¨ãã£ãæ¢åã®çæ³ããçè«ã¨ææ³ãåãå ¥ãããçµ±åçå¿ççæ³ã§ãã[2]ã ã¹ãã¼ãçæ³ã«ã¯4ã¤ã®ä¸»è¦ã³ã³ã»ãããåå¨ããããã¯æ©æä¸é©å¿ã¹ãã¼ãï¼ãããã¯åã«ã¹ãã¼ãï¼ãã³ã¼ãã³ã°ã¹ã¿ã¤ã«ãã¹ãã¼ãã¢ã¼ããä¸æ ¸çææ è¦æ±ã§ãã[3] èªç¥å¿çå¦ã«ããã¦ã¹ãã¼ãï¼schemaï¼ã¨ã¯ãæèã¨è¡åã«ãããçµç¹åããããã¿ã¼ã³ã¨ããã¦ãããããã¯å å ¥è¦³ã«ç±æ¥ããç²¾ç¥æ§é ãä¸çã®ä½ããã®é¢ãè¨è¼ãããã¬ã¼ã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}